遗传性胰腺癌。
Inherited pancreatic cancer.
作者信息
Chen Fei, Roberts Nicholas J, Klein Alison P
机构信息
Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Pathology, Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institution, Baltimore, MD, USA.
出版信息
Chin Clin Oncol. 2017 Dec;6(6):58. doi: 10.21037/cco.2017.12.04.
Abstract
Pancreatic cancers arise through a series of genetic events both inherited and acquired. Inherited genetic changes, both high penetrance and low penetrance, are an important component of pancreatic cancer risk, and may be used to characterize populations who will benefit from early detection. Furthermore, pancreatic cancer patients with inherited mutations may be particularly sensitive to certain targeted agents, providing an opportunity to personalized treatment. Family history of pancreatic cancer is one of the strongest risk factors for the disease, and is associated with an increased risk of caners at other sites, including but not limited to breast, ovarian and colorectal cancer. The goal of this chapter is to discuss the importance of family history of pancreatic cancer, and the known genes that account for a portion of the familial clustering of pancreatic cancer.
摘要
胰腺癌通过一系列遗传事件发生，这些事件既有遗传的，也有后天获得的。高外显率和低外显率的遗传变化都是胰腺癌风险的重要组成部分，可用于确定哪些人群将从早期检测中获益。此外，具有遗传突变的胰腺癌患者可能对某些靶向药物特别敏感，这为个性化治疗提供了机会。胰腺癌家族史是该疾病最强的风险因素之一，并且与其他部位癌症的风险增加相关，包括但不限于乳腺癌、卵巢癌和结直肠癌。本章的目的是讨论胰腺癌家族史的重要性，以及导致胰腺癌家族聚集现象一部分的已知基因。
相似文献
1
Inherited pancreatic cancer.遗传性胰腺癌。
Chin Clin Oncol. 2017 Dec;6(6):58. doi: 10.21037/cco.2017.12.04.
2
Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.特拉华州家族性胰腺癌的全州回顾性研究以及胰腺癌家族中基因突变的频率。
Ann Surg Oncol. 2016 May;23(5):1729-35. doi: 10.1245/s10434-015-5026-x. Epub 2016 Jan 4.
3
Familial pancreatic cancer: Concept, management and issues.家族性胰腺癌：概念、管理与问题
World J Gastroenterol. 2017 Feb 14;23(6):935-948. doi: 10.3748/wjg.v23.i6.935.
4
5
Assessment of "gene-environment" interaction in cases of familial and sporadic pancreatic cancer.家族性和散发性胰腺癌病例中“基因-环境”相互作用的评估。
J Gastrointest Surg. 2009 Aug;13(8):1487-94. doi: 10.1007/s11605-009-0923-6. Epub 2009 May 21.
6
Germline mutations in Japanese familial pancreatic cancer patients.日本家族性胰腺癌患者的种系突变
Oncotarget. 2016 Nov 8;7(45):74227-74235. doi: 10.18632/oncotarget.12490.
7
Familial pancreatic cancer--status quo.家族性胰腺癌——现状。
Int J Colorectal Dis. 2014 Feb;29(2):139-45. doi: 10.1007/s00384-013-1760-3. Epub 2013 Aug 16.
8
Inherited pancreatic cancer: improvements in our understanding of genetics and screening.遗传性胰腺癌：我们对遗传学和筛查认识的进展
Int J Biochem Cell Biol. 2004 Aug;36(8):1386-92. doi: 10.1016/j.biocel.2004.02.010.
9
Familial pancreatic cancer.家族性胰腺癌
Cancer J. 2001 Jul-Aug;7(4):266-73.
10
Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.高危患者胰腺癌常见易感性变异的关联研究：一项PACGENE研究
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1185-91. doi: 10.1158/1055-9965.EPI-15-1217. Epub 2016 May 16.
引用本文的文献
1
Endoscopic innovations in diagnosis and management of pancreatic cancer: a narrative review and future directions.胰腺癌诊断与治疗中的内镜创新：一篇叙述性综述及未来方向
Therap Adv Gastroenterol. 2024 Dec 10;17:17562848241297434. doi: 10.1177/17562848241297434. eCollection 2024.
2
Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer.用于胰腺癌诊断和治疗的分子靶点。
Int J Mol Sci. 2024 Oct 9;25(19):10843. doi: 10.3390/ijms251910843.
3
Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization.自噬相关基因多态性作为胰腺癌易感性生物标志物的研究：三个大型欧洲队列的荟萃分析及功能特征分析。
Int J Cancer. 2025 Jan 15;156(2):339-352. doi: 10.1002/ijc.35196. Epub 2024 Sep 25.
4
The concomitant use of the renin-angiotensin system inhibitors and survival outcomes of patients with pancreatic adenocarcinoma: an analysis from a tertiary center.肾素-血管紧张素系统抑制剂的联合使用与胰腺腺癌患者的生存结局：来自三级中心的分析
Ther Adv Med Oncol. 2024 May 6;16:17588359241247019. doi: 10.1177/17588359241247019. eCollection 2024.
5
Pancreatic ductal adenocarcinoma: exploring clinicopathological trends and racial disparities in a comprehensive U.S. population-based study.胰腺导管腺癌：在美国综合人群中探索临床病理趋势和种族差异的研究。
Clin Transl Oncol. 2024 Oct;26(10):2618-2628. doi: 10.1007/s12094-024-03484-7. Epub 2024 Apr 14.
6
Genetic Signature of Human Pancreatic Cancer and Personalized Targeting.人类胰腺癌细胞的遗传特征与个体化靶向治疗
Cells. 2024 Mar 29;13(7):602. doi: 10.3390/cells13070602.
7
Biomarkers for Early Cancer Detection: A Landscape View of Recent Advancements, Spotlighting Pancreatic and Liver Cancers.早期癌症检测的生物标志物：近期进展全景，聚焦胰腺癌和肝癌
ACS Pharmacol Transl Sci. 2024 Feb 14;7(3):586-613. doi: 10.1021/acsptsci.3c00346. eCollection 2024 Mar 8.
8
Identification of key biomarkers and associated pathways of pancreatic cancer using integrated transcriptomic and gene network analysis.运用整合转录组学和基因网络分析鉴定胰腺癌的关键生物标志物及相关通路
Saudi J Biol Sci. 2023 Nov;30(11):103819. doi: 10.1016/j.sjbs.2023.103819. Epub 2023 Sep 26.
9
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes.在一组携带 BRCA1 和 BRCA2 基因种系意义不明变异（VUS）的胰腺癌患者中，临床结局和化疗反应。
Cancer Chemother Pharmacol. 2023 Dec;92(6):501-510. doi: 10.1007/s00280-023-04585-w. Epub 2023 Sep 19.
10
The anti-cancer effect and mechanism of animal scale-derived extract on malignant melanoma cells.动物鳞片提取物对恶性黑素瘤细胞的抗癌作用及机制。
Sci Rep. 2023 Aug 2;13(1):12548. doi: 10.1038/s41598-023-39742-x.
本文引用的文献
1
FAM19A5, a brain-specific chemokine, inhibits RANKL-induced osteoclast formation through formyl peptide receptor 2.FAM19A5，一种脑特异性趋化因子，通过甲酰肽受体 2 抑制 RANKL 诱导的破骨细胞形成。
Sci Rep. 2017 Nov 14;7(1):15575. doi: 10.1038/s41598-017-15586-0.
2
Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.北欧人群的全基因组关联研究和荟萃分析重复了多个结直肠癌风险位点。
Int J Cancer. 2018 Feb 1;142(3):540-546. doi: 10.1002/ijc.31076. Epub 2017 Oct 12.
3
Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression.沉默 BACH1 通过改变转移相关基因表达抑制前列腺癌细胞的侵袭和迁移。
Artif Cells Nanomed Biotechnol. 2018 Nov;46(7):1495-1504. doi: 10.1080/21691401.2017.1374284. Epub 2017 Sep 11.
4
Expression of transcription factor genes in cell lines corresponding to different stages of pancreatic cancer progression.对应于胰腺癌进展不同阶段的细胞系中转录因子基因的表达
Dokl Biochem Biophys. 2017 Jul;475(1):267-270. doi: 10.1134/S160767291704007X. Epub 2017 Sep 2.
5
Expression of master regulatory genes of embryonic development in pancreatic tumors.胚胎发育主要调控基因在胰腺肿瘤中的表达。
Dokl Biochem Biophys. 2017 Jul;475(1):250-252. doi: 10.1134/S1607672917040020. Epub 2017 Sep 2.
6
Nationwide survey of hereditary pancreatitis in Japan.日本遗传性胰腺炎的全国性调查。
J Gastroenterol. 2018 Jan;53(1):152-160. doi: 10.1007/s00535-017-1388-0. Epub 2017 Aug 31.
7
linc00673 (ERRLR01) is a prognostic indicator of overall survival in breast cancer.长链非编码RNA 00673（ERRLR01）是乳腺癌总生存的一个预后指标。
Transcription. 2018;9(1):17-29. doi: 10.1080/21541264.2017.1329684. Epub 2017 Oct 4.
8
ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage.ATM 缺陷导致基因组不稳定性使胰腺导管腺癌细胞对治疗诱导的 DNA 损伤敏感。
Cancer Res. 2017 Oct 15;77(20):5576-5590. doi: 10.1158/0008-5472.CAN-17-0634. Epub 2017 Aug 8.
9
Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome.满足林奇综合征阿姆斯特丹标准的家族中的癌症风险。
JAMA Oncol. 2017 Dec 1;3(12):1697-1701. doi: 10.1001/jamaoncol.2017.0769.
10
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.明显散发型胰腺腺癌患者中的有害生殖系突变
J Clin Oncol. 2017 Oct 20;35(30):3382-3390. doi: 10.1200/JCO.2017.72.3502. Epub 2017 Aug 2.
Zotero 插件